These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 19621385)
1. Synergistic antitumor effects of FGFR2 inhibitor with 5-fluorouracil on scirrhous gastric carcinoma. Yashiro M; Shinto O; Nakamura K; Tendo M; Matsuoka T; Matsuzaki T; Kaizaki R; Miwa A; Hirakawa K Int J Cancer; 2010 Feb; 126(4):1004-16. PubMed ID: 19621385 [TBL] [Abstract][Full Text] [Related]
2. A novel molecular targeting compound as K-samII/FGF-R2 phosphorylation inhibitor, Ki23057, for Scirrhous gastric cancer. Nakamura K; Yashiro M; Matsuoka T; Tendo M; Shimizu T; Miwa A; Hirakawa K Gastroenterology; 2006 Nov; 131(5):1530-41. PubMed ID: 17101326 [TBL] [Abstract][Full Text] [Related]
3. Establishment of a New Scirrhous Gastric Cancer Cell Line with FGFR2 Overexpression, OCUM-14. Okuno T; Yashiro M; Masuda G; Togano S; Kuroda K; Miki Y; Hirakawa K; Ohsawa M; Wanibuchi H; Ohira M Ann Surg Oncol; 2019 Apr; 26(4):1093-1102. PubMed ID: 30652228 [TBL] [Abstract][Full Text] [Related]
4. A FGFR2 inhibitor, Ki23057, enhances the chemosensitivity of drug-resistant gastric cancer cells. Qiu H; Yashiro M; Zhang X; Miwa A; Hirakawa K Cancer Lett; 2011 Aug; 307(1):47-52. PubMed ID: 21482024 [TBL] [Abstract][Full Text] [Related]
5. Combination effect of a TGF-beta receptor kinase inhibitor with 5-FU analog S1 on lymph node metastasis of scirrhous gastric cancer in mice. Shinto O; Yashiro M; Kawajiri H; Shimizu K; Shimizu T; Miwa A; Hirakawa K Cancer Sci; 2010 Aug; 101(8):1846-52. PubMed ID: 20518790 [TBL] [Abstract][Full Text] [Related]
6. Synergistic antiproliferative effect of mTOR inhibitors in combination with 5-fluorouracil in scirrhous gastric cancer. Matsuzaki T; Yashiro M; Kaizaki R; Yasuda K; Doi Y; Sawada T; Ohira M; Hirakawa K Cancer Sci; 2009 Dec; 100(12):2402-10. PubMed ID: 19764996 [TBL] [Abstract][Full Text] [Related]
7. Effects of VEGFR-3 phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma model. Yashiro M; Shinto O; Nakamura K; Tendo M; Matsuoka T; Matsuzaki T; Kaizaki R; Ohira M; Miwa A; Hirakawa K Br J Cancer; 2009 Oct; 101(7):1100-6. PubMed ID: 19738610 [TBL] [Abstract][Full Text] [Related]
8. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene. Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791 [TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of oxymatrine and angiogenesis inhibitor NM-3 on modulating apoptosis in human gastric cancer cells. Song MQ; Zhu JS; Chen JL; Wang L; Da W; Zhu L; Zhang WP World J Gastroenterol; 2007 Mar; 13(12):1788-93. PubMed ID: 17465467 [TBL] [Abstract][Full Text] [Related]
11. FGFR2 gene amplification in gastric cancer predicts sensitivity to the selective FGFR inhibitor AZD4547. Xie L; Su X; Zhang L; Yin X; Tang L; Zhang X; Xu Y; Gao Z; Liu K; Zhou M; Gao B; Shen D; Zhang L; Ji J; Gavine PR; Zhang J; Kilgour E; Zhang X; Ji Q Clin Cancer Res; 2013 May; 19(9):2572-83. PubMed ID: 23493349 [TBL] [Abstract][Full Text] [Related]
12. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma. Kim R; Tanabe K; Inoue H; Toge T Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567 [TBL] [Abstract][Full Text] [Related]
13. [Expression of livin in gastric cancer and effect of silencing of the livin gene on apoptosis in gastric cancer cells]. Liu P; Wang TS; You SH; Ge HM Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):570-4. PubMed ID: 18210873 [TBL] [Abstract][Full Text] [Related]
14. Tranilast and cisplatin as an experimental combination therapy for scirrhous gastric cancer. Murahashi K; Yashiro M; Inoue T; Nishimura S; Matsuoka T; Sawada T; Sowa M; Hirakawa-Ys Chung K Int J Oncol; 1998 Dec; 13(6):1235-40. PubMed ID: 9824637 [TBL] [Abstract][Full Text] [Related]
15. Serine threonine kinase 11/liver kinase B1 mutation in sporadic scirrhous-type gastric cancer cells. Nishimura S; Yashiro M; Sera T; Yamamoto Y; Kushitani Y; Sugimoto A; Kushiyama S; Togano S; Kuroda K; Okuno T; Murakami Y; Ohira M Carcinogenesis; 2020 Nov; 41(11):1616-1623. PubMed ID: 32236518 [TBL] [Abstract][Full Text] [Related]
16. [Mechanisms responsible for the progression of scirrhous gastric cancer]. Yashiro M; Ohira M; Muguruma K; Shinto O; Hirakawa K Nihon Rinsho; 2012 Oct; 70(10):1812-6. PubMed ID: 23198567 [TBL] [Abstract][Full Text] [Related]
17. The significance of scirrhous gastric cancer cell lines: the molecular characterization using cell lines and mouse models. Yashiro M; Matsuoka T; Ohira M Hum Cell; 2018 Oct; 31(4):271-281. PubMed ID: 29876827 [TBL] [Abstract][Full Text] [Related]
18. Sensitivity of scirrhous gastric cancer to 5-fluorouracil and the role of cancer cell-stromal fibroblast interaction. Nakajima K; Okita Y; Matsuda S Oncol Rep; 2004 Jul; 12(1):85-90. PubMed ID: 15201964 [TBL] [Abstract][Full Text] [Related]
20. Chemosensitivity test is useful in evaluating the appropriate adjuvant cancer chemotherapy for stage III non-scirrhous and scirrhous gastric cancers. Abe S; Kubota T; Matsuzaki SW; Otani Y; Watanabe M; Teramoto T; Kumai K; Kitajima M Anticancer Res; 1999; 19(5C):4581-6. PubMed ID: 10650814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]